If the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: Registrants telephone number, including area code (610) 558-9800įormer name or former address, if changed since last report (Exact name of registrant as specified in its charter) Form 8-Kĭate of Report (Date of Earliest Event Reported): April 11, 2011 (April 10, 2011) Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.Endo Pharmaceuticals Holdings Inc. Slide Presentation of Endo Pharmaceuticals Holdings Inc. Their most directly comparable GAAP financial measures as provided in this slide presentation. Investors are encouraged to review the reconciliation of the non-GAAP financial measures used in this presentation to Of Directors in assessing the performance and compensation of substantially all of its employees, including its executive officers. Finally, these measures are considered by the Compensation Committee of Endos Board Measures may be useful to investors as it is aware that certain of its significant stockholders utilize these measures to evaluate its financial performance. Further, Endo believes that these non-GAAP financial Historically reported similar non-GAAP financial measures to its investors and believes that the inclusion of comparative numbers provides consistency in its financial reporting at this time. These non-GAAP financial measures because it believes they are useful to investors in allowing for greater transparency related to supplemental information used by Endo in its financial and operational decision-making. For instance, Endo believes that these non-GAAP financial measures facilitate its internal comparisons to its historical operating results and comparisons to competitors results. Endo refers to these non-GAAP financial measures in making operating decisions because it believes they provide meaningful supplemental information regarding theĬompanys operational performance. These non-GAAP financial measures are not prepared in accordance with accounting principles generally accepted in the United StatesĪnd may be different from non-GAAP financial measures used by other companies. The adjusted diluted earnings per share are non-GAAP financial measures. Specifically, the presentation refers to adjusted diluted earnings per share. We refer to these as non-GAAP financial measures. This slide presentation includes financial measures that are not in conformity with accounting principles generally accepted in Morgan Global High Yield & Leveraged Finance Conference, a copy of which presentation is filed herewith as Exhibit 99.1 and is incorporated herein by March 2, 2011, the Registrant intends to make a slide presentation at the J.P. Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Date of Report (Date of Earliest Event Reported): March 2, 2011 (March 2, 2011)
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |